Consensus report from the 10th Global Forum for Liver Magnetic Resonance Imaging: developments in HCC management

The 10th Global Forum for Liver Magnetic Resonance Imaging (MRI) was held as a virtual 2-day meeting in October 2021, attended by delegates from North and South America, Asia, Australia, and Europe. Most delegates were radiologists with experience in liver MRI, with representation also from specialists in liver surgery, oncology, and hepatology.Presentations, discussions, and working groups at the Forum focused on the following themes:& BULL; Gadoxetic acid in clinical practice: Eastern and Western perspectives on current uses and challenges in hepatocellular carcinoma (HCC) screening/surveillance, diagnosis, and management & BULL; Economics and outcomes of HCC imaging & BULL; Radiomics, artificial intelligence (AI) and deep learning (DL) applications of MRI in HCC.These themes are the subject of the current manuscript. A second manuscript discusses multidisciplinary tumor board perspectives: how to approach early-, mid-, and late-stage HCC management from the perspectives of a liver surgeon, interventional radiologist, and oncologist (Taouli et al, 2023).Delegates voted on consensus statements that were developed by working groups on these meeting themes. A consensus was considered to be reached if at least 80% of the voting delegates agreed on the statements.

Automated summary

The 10th Global Forum for Liver Magnetic Resonance Imaging (MRI) was a virtual meeting attended by delegates from different continents. The discussions focused on Gadoxetic acid in clinical practice, the economics and outcomes of HCC imaging, and the applications of radiomics, AI, and DL in HCC. The conclusions reached during the meeting were based on the consensus statements developed by working groups.